B P International

 Sexually transmitted infections are most commonly caused by Chlamydia trachomatis (STIs). If undetected and untreated, chlamydial infections can have catastrophic repercussions. Patients that are infected spread the disease to their partners. The goal of this study was to determine the prevalence of genital Chlamydia and its relationship to bacterial flora in STI patients visiting STI clinics, to identify C. Trachomatis Antigen by Immunochromatography, to detect C. Trachomatis Antibody (IgG) by ELISA, and to look for possible associations between C. Trachomatis and other bacteria. Methods: Blood and genital discharge specimens (Endocervical and Vaginal) were collected from 226 patients using standard techniques. Bacterial flora were isolated and identified using traditional methods. An Immunochromatographic assay (Biomerieux) and an ELISA were used to check for the presence of Chlamydia trachomatis antigen and antibody in the patients (Novatech, Germany). Inclusion bodies were...

  The goal of this study was to establish chlamydia trachomatis seroprevalence and its relationship to several epidemiological variables. Chlamydia trachomatis is the most prevalent cause of sexually transmitted infections (STIs). Chlamydial infections that go undiagnosed and untreated might have long-term repercussions. Infected patients are a source of infection for their partners. The purpose of this study was to determine the epidemiological symptoms and seroprevalence of genital Chlamydia in female STI patients who visited STI clinics. In 226 clinically suspected cases of Sexually Transmitted Infection (STI) patients attending a STI clinic, the seroprevalence of chlamydia trachomatis, as well as age, marital status, history of sexual contact, and contraceptive use, were assessed. Patients were tested for the presence of chlamydia trachomatis IgG antibodies using an ELISA (Novatech, Germany) assay. The seroprevalence of chlamydia trachomatis IgG was found to be 55.66 percent by...

The dynamics of Chlamydia trachomatis infection in a human carrier are described in this work using a mathematical model. It has been suggested that protective immunity against Chlamydia is dominated by cell-mediated immunity rather than humoral immunity. The model had useful features like drug administration-assisted recuperation. Actual solutions were used to test the existence and uniqueness of model solutions. The model is subjected to local and global stability analysis. It is stable under certain conditions, according to the results. Analytically, the system of equations was solved using the parameter-expanding approach and direct integration. The findings are visually shown and explained. The impact of burst size per infected cell, rate of cell infection, and recovery rate owing to medication delivery has been discovered to be fairly significant.   Author (S) Details O. N. Emuoyibofarhe Department of Computer Science and Information Technology, Bowen University, Iwo,...